McCollister-Slipp to Speak at GlobalWIN Luncheon on House Energy and Commerce Committee’s 21st Century Cures Initiative

logo_globalwin_620x130_72dpi EnergyCommerceLogo_ORANGE-150x150

(Washington, DC – April 20, 2015) – On Wednesday, April 22, Galileo Analytics Co- Founder Anna McCollister-Slipp will join Congressman Fred Upton, Chairman of the House Committee on Energy and Commerce, as well as representatives from Pfizer, Novartis and Faster Cures at a Global Women Innovation Network (GlobalWIN) luncheon, to discuss the 21st Century Cures Initiative.

Spearheaded by Chairman Upton (R-MI) and Rep. Diana DeGette (D-CO), the bi-
partisan 21st Century Cures Initiative is aimed at developing legislation that will enable and accelerate the discovery, development and delivery of new treatments, while building our nation’s capacity to continue to serve as the global hub of biomedical innovation.

Congressman Upton will provide introductory remarks, followed by a panel discussion, which includes McCollister-Slipp, along with women leaders from pharma, the Hill and patient advocacy.

More information about the luncheon is below:

Global Women’s Innovation Network Luncheon on Innovation in Healthcare in the 21st Century

Introductory remarks by Congressman Fred Upton. Chairman, House Committee on Energy and Commerce

Followed by a panel discussion featuring:

Kirsten Axelsen
Vice President of Worldwide Policy, Pfizer, Inc.

Cathryn M. Clary, MD
Head of US Medical and Chief Scientific Officer for
US General Medicines Novartis Pharmaceuticals Corporation

Anna McCollister-Slipp
Co-Founder, Galileo Analytics

Margaret Anderson
Executive Director, Faster Cures

Carly McWilliams (moderator)
Professional Staff, Subcommittee on Health, US House of Representatives Committee on Energy and Commerce

Wednesday, April 22nd, 2015
12:00pm – 1:30pm

McDermott Will & Emery
The McDermott Building
500 North Capitol Street, NW
Washington, DC

Space is Limited. RSVP to Annele Jones at Annele@HelenMilby.com

About the 21st Century Cures Initiative

In April 2014, Energy and Commerce Committee Chairman Fred Upton (R-MI) partnered with Rep. Diana DeGette (DCO) to launch the 21st Century Cures initiative. It has been reported that among the 10,000 known diseases, 7,000 of which are considered rare, there are treatments for only 500. According to Dr. Francis Collins, Director of the National Institutes of Health (NIH), it now takes “around 14 years and $2 billion or more” to develop a new drug and “more than 95 percent of [such] drugs fail during development.” Over the course of the last year, patients, providers, innovators, regulators, and researchers from around the country have provided a wide range of specific ideas on how Congress can help accelerate the discovery, development, and delivery of promising new treatments and cures for patients and maintain our nation’s standing as the biomedical innovation capital of the world. While it remains a work in progress, the legislative language included in the discussion document is based on such ideas, including proposals authored by both Republicans and Democrats.

About GlobalWIN

GlobalWIN is a 501(c)(3) organization co-chaired by Congresswoman Martha Roby and Congresswoman Debbie Wasserman Schultz that provides a dynamic forum for women executives and thought leaders in academia, government, and business who are passionate about innovation and its potential to advance critical policy issues.

###

Loading

Galileo Analytics’ McCollister Slipp Featured on HuffPost Live’s Davos Coverage

(Washington, DC – January 23, 2015) – Today on HuffingtonPost Live, Galileo Analytics Co-Founder Anna McCollister-Slipp called on those attending the World Economic Forum in Davos to commit to making digital health data more available to patients, physicians and researchers. McCollister-Slipp made her comments as part of the HuffPost Live’s coverage of the World Economic Forum’s annual gathering in Davos, Switzerland.

“I’m particularly excited that the World Economic Forum is taking on the issue of digital health at this year’s meeting, because many of the issues that are keeping us from going as far as we could with today’s technology tend to be economic decisions by corporations who have a false sense of ownership over patient data or refuse to open up data streams through APIs, so that independent developers can develop technologies that patients will use,” she said.

Echoing her comments from a column she wrote in late 2014 for the Huffington Post titled The Grim Reality of Digital Health Today, McCollister-Slipp said most investment in digital health tools are directed toward those who are focused on wellness tools or activity trackers, rather than applications aimed at helping patients manage disease, adding that those in Davos should think more strategically about how they direct their dollars to get the most from digital health investments.

“If we can get the world’s economic leaders in Davos to make this a priority, we can get really far really quickly,” she said.

McCollister-Slipp was one of three panelists interviewed by HuffPost Live anchor Nancy Redd. Other panelists included Chris Fabian, Co-Founder, UNICEF Innovation Unit and Shannon Firth, Contributor, MedPage Today.

For the full HuffPost Live segment on The Digital Health Revolution and Davos, click here.

###

Loading

McCollister-Slipp to Clinical Researchers: Find Ways to Incorporate Patient-Generated Health Data into Clinical Trials

(New York, NY – November 17, 2014) – Galileo Analytics Co-Founder Anna McCollister-Slipp today called on pharmaceutical companies and the Food and Drug Administration to find ways to incorporate new forms of patient-generated health data into clinical trials. McCollister-Slipp made her remarks as part of a panel on patient-generated health data at this year’s Partnering for Cures conference in New York, sponsored by Faster Cures and the Milken Institute.

McCollister-Slipp was among a select group of genomics experts, researchers and technology developers discussing the promise of new digital health and genomic data sources for transforming clinical research, as well as the barriers to including new, innovative patient-generated data streams into clinical research. Panel members included:

Eric Green, Director, National Human Genome Research Institute, National Institutes of Health
Anna McCollister-Slipp, Co-Founder, Galileo Analytics
Tom Parsons, Co-Founder, HealthXL
Eric Schadt, Director of the Icahn Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences, and the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine, Mount Sinai
Ravi Seshadri, Vice President, Technology, NantHealth
Todd Sherer, CEO, The Michael J. Fox Foundation for Parkinson’s Research (moderator)

McCollister-Slipp appealed to Pharmaceutical and medical device researches to bring patients into the process of designing research protocols, which she says might help increase the patient participation in clinical research.

Referencing a clinical trial for a new diabetes drug in which she participated in 2013, she said “Everything about the trial process was designed for the convenience of everybody in the study process but the patients. Despite the fact that one of the big buzzwords in recent years is patient-centeredness, It was painfully obvious that the protocol designers had never consulted anybody who had lived with the disease.”

For a full video and more coverage of the panel click here.

###

Loading

Galileo Analytics Co-Founder Featured in US News’ Annual Hospital Rankings Issue

(Washington, DC – August 4, 2014) – The 2014 edition of US News and World Report’s annual “Best Hospitals” issue hit the stands today, featuring Galileo Analytics Co-Founder Anna McCollister-Slipp in an article about the future of digital health.

Written by veteran journalist Elizabeth Gardner, the article discusses McCollister-Slipp’s use of digital health and wellness tools to manage her type 1 diabetes and the promise of these digital technologies to transform healthcare, as well as her frustration with a lack of data access and medical device interoperability and how that unnecessarily inhibits the devices’ value for patients.

In addition to McCollister-Slipp, the article features noted digital health experts, such as Dr. Eric Topol of the Scripps Translational Science Institute, Dr. Danny Sands of the Beth Israel Deaconess Medical Center and Co-Founder of the Society for Participatory Medicine and Dr. Farzad Mostashari, former National Coordinator of the Office of Information Technology at the Department of Health and Human Services.

To read the full article visit www.health.usnews.com or click here: “Need a Diagnosis or Checkup? Your Smartphone Is On Call: Apps and handheld devices are revolutionizing care”

###

Loading